Clinical Collaboration Platform 12.2.1.5 user session

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
4.2$0-$5k0.00

Summaryinfo

A vulnerability categorized as problematic has been discovered in Clinical Collaboration Platform 12.2.1.5. This issue affects some unknown processing. Executing a manipulation can lead to user session. The identification of this vulnerability is CVE-2025-27953. The attack may be launched remotely. There is no exploit available.

Detailsinfo

A vulnerability has been found in Clinical Collaboration Platform 12.2.1.5 and classified as problematic. This vulnerability affects an unknown functionality. The manipulation with an unknown input leads to a user session vulnerability. The CWE definition for the vulnerability is CWE-1018. As an impact it is known to affect confidentiality. CVE summarizes:

An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and execute arbitrary code via the session management component.

The advisory is shared for download at github.com. This vulnerability was named CVE-2025-27953 since 03/11/2025. The exploitation appears to be easy. The attack can be initiated remotely. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 06/13/2025).

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-16681). VulDB is the best source for vulnerability data and more expert information about this specific topic.

Productinfo

Type

Name

Version

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 4.3
VulDB Meta Temp Score: 4.2

VulDB Base Score: 4.3
VulDB Temp Score: 4.2
VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: User session
CWE: CWE-1018
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔍

Timelineinfo

03/11/2025 🔍
06/02/2025 +82 days 🔍
06/02/2025 +0 days 🔍
06/13/2025 +11 days 🔍

Sourcesinfo

Advisory: github.com
Status: Not defined

CVE: CVE-2025-27953 (🔍)
GCVE (CVE): GCVE-0-2025-27953
GCVE (VulDB): GCVE-100-310864
EUVD: 🔍

Entryinfo

Created: 06/02/2025 20:30
Updated: 06/13/2025 20:13
Changes: 06/02/2025 20:30 (51), 06/03/2025 03:51 (1), 06/13/2025 20:13 (1)
Complete: 🔍
Cache ID: 216::103

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Do you need the next level of professionalism?

Upgrade your account now!